<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="correction" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">857986</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2022.857986</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: LncRNA SOX2-OT/miR-30d-5p/PDK1 Regulates PD-L1 Checkpoint Through the mTOR Signaling Pathway to Promote Non-Small Cell Lung Cancer Progression and Immune Escape</article-title>
<alt-title alt-title-type="left-running-head">Chen et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Corrigendum: SOX2-OT Promotes Progression of NSCLC</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chen</surname>
<given-names>Zhoumiao</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1252102/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Zhao</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Shaohua</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Qiang</given-names>
</name>
</contrib>
</contrib-group>
<aff>
<institution>Department of Thoracic Surgery</institution>, <institution>Sir Run Run Shaw Hospital</institution>, <institution>School of Medicine</institution>, <institution>Zhejiang University</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Approved by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/20182">Frontiers Editorial Office</ext-link>, Frontiers Media SA, Switzerland</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Zhoumiao Chen, <email>3193084@zju.edu.cn</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>857986</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>01</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>01</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Chen, Chen, Xu and Zhang.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Chen, Chen, Xu and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front. Genet." journal-id-type="nlm-ta" xlink:href="10.3389/fgene.2021.674856" ext-link-type="doi">A corrigendum on <article-title>LncRNA SOX2-OT/miR-30d-5p/PDK1 Regulates PD-L1 Checkpoint Through the mTOR Signaling Pathway to Promote Non-small Cell Lung Cancer Progression and Immune Escape</article-title> by Chen, Z., Chen, Z., Xu, S., and Zhang, Q. (2021). Front. Genet. 12:674856. doi: <object-id>10.3389/fgene.2021.674856</object-id>
</related-article>
<kwd-group>
<kwd>non-small cell lung cancer</kwd>
<kwd>competing endogenous RNA</kwd>
<kwd>SOX2-OT</kwd>
<kwd>mTOR</kwd>
<kwd>PD-L1</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>There is an error in the Funding statement. The correct number for Zhejiang Provincial Natural</p>
<p>Science Foundation of China &#x201c;No. Q19H280028&#x201d; is &#x201c;No. LQ19H280007.&#x201d;</p>
<p>The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
</body>
<back>
<sec sec-type="disclaimer" id="s1">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>